IDBS Acquires InforSense to Provide End-to-End Solutions for R&D Data Management
News Jun 29, 2009
IDBS has announced that it has concluded an unconditional agreement to acquire InforSense Ltd (InforSense), a company providing scientific and business intelligence (BI) technologies, in an all-cash transaction. The acquisition will complete in July.
R&D organizations in the public and private sectors rely upon their ability to capture, integrate and interpret their data. This is hampered by the explosion in volume and diversity of data available to scientists, the global scale of modern R&D activities and the requirement for data to be accessed and searched in context.
InforSense’s data integration technologies and web-based interactive analytics complement IDBS’ suite of secure, context-rich data management solutions. This transaction creates a supplier who can deliver the entire capture, integration and decision-making infrastructure for R&D organizations worldwide.
With the addition of the InforSense product portfolio, IDBS will expand its large scale data integration activities to support international data sharing and broaden its life sciences portfolio into the emerging growth area of biomarker development and personalized medicine.
Inside cells, where DNA is packed tightly in the nucleus and rigid proteins keep intricate transport systems on track, some molecules can simply self-organize, find one another in crowded spaces, and quickly coalesce into droplets. Now, new research shows how proteins that organize into liquid droplets inside cells make certain biological functions possible.
About 422 million people around the world, including more than 30 million Americans, have diabetes. Obesity is the most significant risk factor for type 2 diabetes. yet about 30 percent of obese people do not develop type 2 diabetes or other metabolic conditions. New research aims to understand on a cellular level, how this separation occurs.READ MORE